Simone Mingels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simone Mingels has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Andre Dekker
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
3 shared publications - Ekaterina Sergeevna Akhmad
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
3 shared publications - Hannah Piehl
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht University, Paul Henri Spaaklaan 1, Maastricht, 6229 EN, The Netherlands, +31 (0)43 38 81863
3 shared publications - Johan van Soest
Brightlands Institute for Smart Society (BISS), Faculty of Science and Engineering, Maastricht University, The Netherlands
3 shared publications - Rianne Fijten
Department of Radiation Oncology (Maastro), GROW Institute for Oncology and Reproduction, Maastricht University Medical Centre+, 6229 ER Maastricht, The Netherlands
3 shared publications - Anniek van Hienen
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht University, Paul Henri Spaaklaan 1, Maastricht, 6229 EN, The Netherlands, +31 (0)43 38 81863
2 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13, e99117
Investigating Context in How Clinicians Make Sense of AI: Qualitative Interview Study
Background: AI-driven clinical decision support systems (AI-CDSS) are increasingly being introduced to enhance clinical decision-making, yet their adoption in health care remains limited. Research has examined technical, organizational, and contextual barriers to adoption, but less attention has been paid to how knowledge, values, and responsibility around AI-CDSS are constructed and negotiated in practice. Objective: This study examines how clinicians and AI experts make sense of AI-CDSS by reanalyzing qualitative interview data through a feminist and constructivist science and technology studies (STS) perspective. Whereas the original study examined informational needs, this reanalysis asks how participants construct relevant knowledge, evaluate the value of AI-CDSS, and negotiate appropriate use and responsibility in clinical practice. Methods: The authors conducted a reanalysis of semistructured interviews held in 2024 with clinicians (n=8) and AI experts (n=8) in the Netherlands. The original study focused on informational needs for AI-CDSS. For this analysis, a deductive coding framework based on European Commission guidelines for trustworthy AI was first applied, and the material was then inductively reorganized into 5 empirical themes. Subsequently, feminist and constructivist STS concepts were used as sensitizing concepts in an abductive analysis, and these concepts were brought into dialogue with the empirical themes to examine the sociotechnical relations underlying participants’ accounts. Results: Situated knowledge shows that the informational needs of clinicians are not universal but relate to their roles and specific clinical contexts, with understanding oriented less toward technical transparency than toward actionable guidance, relevance, and integration into decision-making. Standpoint theory illuminates differences between stakeholder priorities: clinicians emphasize information on how to use and act on AI outputs within existing workflows, whereas AI experts focus more on providing technical characteristics and performance metrics. Tinkering captures how clinicians experiment with AI systems in practice to develop situated, lay forms of expertise. Situated value highlights that perceptions of an AI-CDSS’s worth are relational, with clinicians valuing novel, context-sensitive insights and developers prioritizing performance metrics. Finally, response-ability reveals how trust and accountability are largely delegated to institutional structures, while clinicians report limited legal, organizational, and structural support to respond meaningfully to uncertainty or errors when using AI-CDSS. Conclusions: Reanalyzing the same interview material through an abductive STS approach makes sociotechnical dimensions visible that were not the focus of the original analysis. Rather than treating informational requirements as universal or adoption as primarily a matter of technical performance and communication, the findings show how knowledge, value, and responsibility are constituted through situated professional practices and institutional arrangements. Processes and considerations regarding how clinicians make sense of AI-CDSS are not universal but are shaped by social, cultural, and institutional contexts. This analytical perspective underscores the need for context-sensitive, multistakeholder strategies to support meaningful and responsible AI adoption in clinical practice.
- 13 November 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13, e99117
Open AccessInvestigating Context in How Clinicians Make Sense of AI: Qualitative Interview Study
Background: AI-driven clinical decision support systems (AI-CDSS) are increasingly being introduced to enhance clinical decision-making, yet their adoption in health care remains limited. Research has examined technical, organizational, and contextual barriers to adoption, but less attention has been paid to how knowledge, values, and responsibility around AI-CDSS are constructed and negotiated in practice. Objective: This study examines how clinicians and AI experts make sense of AI-CDSS by reanalyzing qualitative interview data through a feminist and constructivist science and technology studies (STS) perspective. Whereas the original study examined informational needs, this reanalysis asks how participants construct relevant knowledge, evaluate the value of AI-CDSS, and negotiate appropriate use and responsibility in clinical practice. Methods: The authors conducted a reanalysis of semistructured interviews held in 2024 with clinicians (n=8) and AI experts (n=8) in the Netherlands. The original study focused on informational needs for AI-CDSS. For this analysis, a deductive coding framework based on European Commission guidelines for trustworthy AI was first applied, and the material was then inductively reorganized into 5 empirical themes. Subsequently, feminist and constructivist STS concepts were used as sensitizing concepts in an abductive analysis, and these concepts were brought into dialogue with the empirical themes to examine the sociotechnical relations underlying participants’ accounts. Results: Situated knowledge shows that the informational needs of clinicians are not universal but relate to their roles and specific clinical contexts, with understanding oriented less toward technical transparency than toward actionable guidance, relevance, and integration into decision-making. Standpoint theory illuminates differences between stakeholder priorities: clinicians emphasize information on how to use and act on AI outputs within existing workflows, whereas AI experts focus more on providing technical characteristics and performance metrics. Tinkering captures how clinicians experiment with AI systems in practice to develop situated, lay forms of expertise. Situated value highlights that perceptions of an AI-CDSS’s worth are relational, with clinicians valuing novel, context-sensitive insights and developers prioritizing performance metrics. Finally, response-ability reveals how trust and accountability are largely delegated to institutional structures, while clinicians report limited legal, organizational, and structural support to respond meaningfully to uncertainty or errors when using AI-CDSS. Conclusions: Reanalyzing the same interview material through an abductive STS approach makes sociotechnical dimensions visible that were not the focus of the original analysis. Rather than treating informational requirements as universal or adoption as primarily a matter of technical performance and communication, the findings show how knowledge, value, and responsibility are constituted through situated professional practices and institutional arrangements. Processes and considerations regarding how clinicians make sense of AI-CDSS are not universal but are shaped by social, cultural, and institutional contexts. This analytical perspective underscores the need for context-sensitive, multistakeholder strategies to support meaningful and responsible AI adoption in clinical practice.
- Open Access
- 9 October 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e92329
AI Model Reporting Standards in Health Care: Systematic Review and Consolidation
Background: AI technologies are currently experiencing significant growth in development and use in health care. The AI model lifecycle includes several stages, all of which should be adequately described. Reporting standards are commonly used for this purpose. However, the plain-text structure of these standards prevents transparent machine-readability of this information. Objective: This systematic review aims to investigate AI model reporting standards from clinical databases and technical documents published since 2016. Methods: The methodological systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. The inclusion criteria of this systematic review were papers published from 2016 to April 2026 in English and in a peer-reviewed journal with open access. We aimed to include standards for different data types (structured, images, and text-based). The exclusion criteria were specific medical domain, incomplete reports, and reviews. The following libraries have been consulted: Scopus and Web of Science, MEDLINE and Embase, the IEEE Xplore digital library, and the ACM Digital Library. We applied an Automated Systematic Review software tool (Utrecht University) to find relevant papers after records retrieval. Two reviewers (EA, DS) screened relevant papers independently and invited a third reviewer (JvS) to reach a consensus. All included papers were analyzed to extract relevant lifecycle stage, publication type, data type, and reporting questions. The results were presented and synthesized in a consolidated list by grouping questions and ordering them in a logical sequence according to the AI model lifecycle. Results: The total number of included studies was 25 from clinical and technical databases (22 and 3, respectively). The consolidated list includes 134 questions ordered in 7 groups: “Problem identification,” “Data collection and processing,” “Model development,” “Technical validation,” “Functional validation,” “Operation & Monitoring,” and one additional group with “Statements.” Groups according to the lifecycle stages contain all relevant information for each stage. Both clinical and technical papers reflect information for “Problem identification” (s=5), “Data collection and processing” (s=25), “Model development” (s=13), “Technical validation” (s=14). While “Functional validation” (s=30) was represented mostly in clinical papers and “Operation & Monitoring” (s=18) in technical ones. In the “Statements” (s=29), all general questions were summarized, describing reusability and reproducibility of the model, and highlighting ethical considerations, such as model fairness, explainability, interpretability, and related risk. It was shown that only 10 out of 15 FAIR (findable, accessible, interoperable, reusable) principles were addressed in the consolidated list, with focus on providing rich metadata (F2) and accurate and relevant descriptions (R1). Conclusions: We furthermore considered the mapping of the consolidated questions with FAIR principles. In future, we aim to incorporate the results of our work into a metadata schema for AI models developed according to FAIR principles.
- 9 October 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e92329
Open AccessAI Model Reporting Standards in Health Care: Systematic Review and Consolidation
Background: AI technologies are currently experiencing significant growth in development and use in health care. The AI model lifecycle includes several stages, all of which should be adequately described. Reporting standards are commonly used for this purpose. However, the plain-text structure of these standards prevents transparent machine-readability of this information. Objective: This systematic review aims to investigate AI model reporting standards from clinical databases and technical documents published since 2016. Methods: The methodological systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. The inclusion criteria of this systematic review were papers published from 2016 to April 2026 in English and in a peer-reviewed journal with open access. We aimed to include standards for different data types (structured, images, and text-based). The exclusion criteria were specific medical domain, incomplete reports, and reviews. The following libraries have been consulted: Scopus and Web of Science, MEDLINE and Embase, the IEEE Xplore digital library, and the ACM Digital Library. We applied an Automated Systematic Review software tool (Utrecht University) to find relevant papers after records retrieval. Two reviewers (EA, DS) screened relevant papers independently and invited a third reviewer (JvS) to reach a consensus. All included papers were analyzed to extract relevant lifecycle stage, publication type, data type, and reporting questions. The results were presented and synthesized in a consolidated list by grouping questions and ordering them in a logical sequence according to the AI model lifecycle. Results: The total number of included studies was 25 from clinical and technical databases (22 and 3, respectively). The consolidated list includes 134 questions ordered in 7 groups: “Problem identification,” “Data collection and processing,” “Model development,” “Technical validation,” “Functional validation,” “Operation & Monitoring,” and one additional group with “Statements.” Groups according to the lifecycle stages contain all relevant information for each stage. Both clinical and technical papers reflect information for “Problem identification” (s=5), “Data collection and processing” (s=25), “Model development” (s=13), “Technical validation” (s=14). While “Functional validation” (s=30) was represented mostly in clinical papers and “Operation & Monitoring” (s=18) in technical ones. In the “Statements” (s=29), all general questions were summarized, describing reusability and reproducibility of the model, and highlighting ethical considerations, such as model fairness, explainability, interpretability, and related risk. It was shown that only 10 out of 15 FAIR (findable, accessible, interoperable, reusable) principles were addressed in the consolidated list, with focus on providing rich metadata (F2) and accurate and relevant descriptions (R1). Conclusions: We furthermore considered the mapping of the consolidated questions with FAIR principles. In future, we aim to incorporate the results of our work into a metadata schema for AI models developed according to FAIR principles.
- Open Access
- 12 March 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12 (1) , e85228
Understanding Clinicians’ Informational Needs for AI-Driven Clinical Decision Support Systems: Qualitative Interview Study
Background: Advancements in artificial intelligence (AI) are transforming health care, particularly through AI-driven clinical decision support systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. Objective: This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel, this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. Methods: A qualitative description design study was conducted using semistructured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards, including Model Cards, Model Facts, and the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis–Artificial Intelligence (TRIPOD-AI) checklist. The transcripts were analyzed through codebook thematic analysis. Results: Four key themes were identified: (1) clinicians need clear information on training data, its origin, size, and inclusion and exclusion criteria, to judge model applicability; (2) performance metrics must go beyond the area under the curve (AUC) and be clinically relevant to support informed decisions; (3) limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; and (4) information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon, and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the usability gap. Conclusions: To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- 12 March 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12 (1) , e85228
Open AccessUnderstanding Clinicians’ Informational Needs for AI-Driven Clinical Decision Support Systems: Qualitative Interview Study
Background: Advancements in artificial intelligence (AI) are transforming health care, particularly through AI-driven clinical decision support systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. Objective: This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel, this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. Methods: A qualitative description design study was conducted using semistructured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards, including Model Cards, Model Facts, and the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis–Artificial Intelligence (TRIPOD-AI) checklist. The transcripts were analyzed through codebook thematic analysis. Results: Four key themes were identified: (1) clinicians need clear information on training data, its origin, size, and inclusion and exclusion criteria, to judge model applicability; (2) performance metrics must go beyond the area under the curve (AUC) and be clinically relevant to support informed decisions; (3) limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; and (4) information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon, and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the usability gap. Conclusions: To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- Open Access
Decisional needs among patients and physicians in the treatment of chronic myeloid leukaemia: a qualitative analysis in the Netherlands
Objective: Treatment advancements in chronic myeloid leukaemia (CML) have made the disease manageable but carry significant risk of side effects. Bridging information gaps between patients and physicians through shared decision-making (SDM) is increasingly favoured, yet understanding treatment complexities remains a challenge. This study sought to identify decisional and informational needs of both patients and physicians in CML care. Design: A qualitative study using semi-structured interviews was conducted to investigate the opinions, attitudes and preferences of both patients with chronic myeloid leukaemia and physicians. Setting: Patients and physicians were recruited through the Dutch CMyLife platform, an initiative of haematologists, patients and patient organisations. They were provided with the participant information and invited to participate if interested. Participants: A total of 15 interviews (n=10 patients, n=5 physicians) were conducted between April and October 2023. Primary and secondary outcome measures: A pre-defined interview guide was developed based on the Decisional Needs Assessment questionnaire. Interview transcripts were thematically analysed. Results: Eight themes and 28 sub-themes were observed, highlighting patient needs, treatment choices and informational preferences. Patients emphasised the importance of understanding medication options and side effects, while physicians stressed the necessity of delivering up-to-date and comprehensible information. Almost all participants had experienced professionals making the treatment decision, without patient involvement, especially when initiating treatment. Some patients expressed too little information and missed partnership with professionals at treatment onset. Peer support, decision-making dynamics and the role of caregivers were also significant considerations. Conclusions: Both shared and distinct perspectives on CML treatment decision-making between patients and physicians were revealed, underscoring the complexity of decisional needs in CML management. The findings emphasise the importance of patient-centred care, SDM and tailored communication strategies to optimise patient outcomes and satisfaction. Improved communication and evidence-based decision-making tools can significantly impact patient well-being. Further research and interventions are necessary to address the challenges in decision-making processes in CML care.
Open AccessDecisional needs among patients and physicians in the treatment of chronic myeloid leukaemia: a qualitative analysis in the Netherlands
Objective: Treatment advancements in chronic myeloid leukaemia (CML) have made the disease manageable but carry significant risk of side effects. Bridging information gaps between patients and physicians through shared decision-making (SDM) is increasingly favoured, yet understanding treatment complexities remains a challenge. This study sought to identify decisional and informational needs of both patients and physicians in CML care. Design: A qualitative study using semi-structured interviews was conducted to investigate the opinions, attitudes and preferences of both patients with chronic myeloid leukaemia and physicians. Setting: Patients and physicians were recruited through the Dutch CMyLife platform, an initiative of haematologists, patients and patient organisations. They were provided with the participant information and invited to participate if interested. Participants: A total of 15 interviews (n=10 patients, n=5 physicians) were conducted between April and October 2023. Primary and secondary outcome measures: A pre-defined interview guide was developed based on the Decisional Needs Assessment questionnaire. Interview transcripts were thematically analysed. Results: Eight themes and 28 sub-themes were observed, highlighting patient needs, treatment choices and informational preferences. Patients emphasised the importance of understanding medication options and side effects, while physicians stressed the necessity of delivering up-to-date and comprehensible information. Almost all participants had experienced professionals making the treatment decision, without patient involvement, especially when initiating treatment. Some patients expressed too little information and missed partnership with professionals at treatment onset. Peer support, decision-making dynamics and the role of caregivers were also significant considerations. Conclusions: Both shared and distinct perspectives on CML treatment decision-making between patients and physicians were revealed, underscoring the complexity of decisional needs in CML management. The findings emphasise the importance of patient-centred care, SDM and tailored communication strategies to optimise patient outcomes and satisfaction. Improved communication and evidence-based decision-making tools can significantly impact patient well-being. Further research and interventions are necessary to address the challenges in decision-making processes in CML care.
- Open Access
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Understanding Clinicians’ Informational Needs for AI-driven Clinical Decision Support Systems: Qualitative Interview Study (Preprint)
BACKGROUND Advancements in Artificial Intelligence (AI) are transforming healthcare, particularly through AI-driven Clinical Decision Support Systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. OBJECTIVE This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. METHODS A qualitative description design study was conducted using semi-structured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards including Model Cards (Mitchell et al., 2019), Model Facts (Sendak et al., 2020), and the TRIPOD-AI checklist (Collins et al., 2015, 2024). The transcripts were analyzed through codebook thematic analysis. RESULTS Four key themes were identified: (i) Clinicians need clear information on training data, its origin, size, and inclusion/exclusion criteria, to judge model applicability; (ii) Performance metrics must go beyond AUC and be clinically relevant to support informed decisions; (iii) Limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; (iv) Information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the current usability gap. CONCLUSIONS To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnderstanding Clinicians’ Informational Needs for AI-driven Clinical Decision Support Systems: Qualitative Interview Study (Preprint)
BACKGROUND Advancements in Artificial Intelligence (AI) are transforming healthcare, particularly through AI-driven Clinical Decision Support Systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. OBJECTIVE This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. METHODS A qualitative description design study was conducted using semi-structured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards including Model Cards (Mitchell et al., 2019), Model Facts (Sendak et al., 2020), and the TRIPOD-AI checklist (Collins et al., 2015, 2024). The transcripts were analyzed through codebook thematic analysis. RESULTS Four key themes were identified: (i) Clinicians need clear information on training data, its origin, size, and inclusion/exclusion criteria, to judge model applicability; (ii) Performance metrics must go beyond AUC and be clinically relevant to support informed decisions; (iii) Limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; (iv) Information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the current usability gap. CONCLUSIONS To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.